Human Vaccines and Immunotherapeutics 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Parental willingness of HPV vaccination in Mainland China: A meta-analysis
Volume 20, Issue 1, December 2024 . (Source: Human Vaccines and Immunotherapeutics)
Source: Human Vaccines and Immunotherapeutics - February 22, 2024 Category: Allergy & Immunology Authors: Sensen TanSumeng WangXunwen ZouXinhua JiaChenyunhao TongJian YinXuemei LianYoulin Qiaoa School of Public Health, Chongqing Medical University, Chongqing, Chinab School of Population Medicine and Public Health, Chinese Academy of Medical Sciences & Peking Source Type: research
A scoping review of active, participant centred, digital adverse events following immunization (AEFI) surveillance of WHO approved COVID-19 vaccines: A Canadian immunization Research Network study
Volume 20, Issue 1, December 2024 . (Source: Human Vaccines and Immunotherapeutics)
Source: Human Vaccines and Immunotherapeutics - February 20, 2024 Category: Allergy & Immunology Authors: Mohamed SerhanAthanasios PsihogiosNooh KabirA. Brianne BotaSalima S. MithaniDavid P. SmithDavid T. ZhuDevon GreysonSarah WilsonDeshayne FellKarina A. TopJulie A. BettingerKumanan Wilsona Clinical Epidemiology Program, Ottawa Hospital Research Institute, O Source Type: research
High impact of quadrivalent human papillomavirus vaccine across racial/ethnic groups: National Health and Nutrition Examination Survey, 2003 –2006 and 2015–2018
Volume 20, Issue 1, December 2024 . (Source: Human Vaccines and Immunotherapeutics)
Source: Human Vaccines and Immunotherapeutics - February 19, 2024 Category: Allergy & Immunology Authors: Ruth StefanosRayleen M. LewisTroy D. QuerecJulia W. GarganoElizabeth R. UngerLauri E. Markowitza Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USAb Epidemic Source Type: research
Perceptions about respiratory syncytial virus (RSV) and attitudes toward the RSV vaccine among the general public in China: A cross-sectional survey
Volume 20, Issue 1, December 2024 . (Source: Human Vaccines and Immunotherapeutics)
Source: Human Vaccines and Immunotherapeutics - February 19, 2024 Category: Allergy & Immunology Authors: Qiang WangShixin XiuLiuqing YangLan LiMin YangXuwen WangYuan ShenWeibing WangLeesa Lina Department of Epidemiology, School of Public Health, Fudan University, Shanghai, Chinab Department of Immunization, Wuxi Center for Disease Control and Prevention, Wux Source Type: research
Development of a quantitative ELISA for SARS-CoV-2 vaccine candidate, NDV-HXP-S, with CpG 1018 ® adjuvant
Volume 20, Issue 1, December 2024 . (Source: Human Vaccines and Immunotherapeutics)
Source: Human Vaccines and Immunotherapeutics - February 19, 2024 Category: Allergy & Immunology Authors: Marcus EstradaChangcheng ZhuAnan BzamiJessica A. WhiteManjari LalMedical Devices and Health Technologies, PATH, Seattle, WA, USA Source Type: research
Real-world data of China: Analysis of HPV vaccine coverage and post-vaccination adverse reaction monitoring in Western Chinese provinces from 2018 to 2021
Volume 20, Issue 1, December 2024 . (Source: Human Vaccines and Immunotherapeutics)
Source: Human Vaccines and Immunotherapeutics - February 19, 2024 Category: Allergy & Immunology Authors: Jing AnYan LiuYingchun MaYong-Zhuo JiaoXue-Feng LiangNa JinJunyi BaoNan JiangXiao-Shu Zhanga Immunization Planning Department, Gansu Provincial Center for Disease Control and Prevention, Lanzhou, Chinab school of public health, Gansu University Of Chinese Source Type: research
Serological assessment of the durability of vaccine-mediated protection against SARS-CoV-2 infection
Volume 20, Issue 1, December 2024 . (Source: Human Vaccines and Immunotherapeutics)
Source: Human Vaccines and Immunotherapeutics - February 16, 2024 Category: Allergy & Immunology Authors: John T. BatesSeth T. LiretteAndrew P. FarmerMichael A. BierdemanKristina B. SeyfarthDallas R. EdererDenise D. MontgomeryGrace C. BurnettAmanda T. PhamGailen D. Marshalla Department of Cell and Molecular Biology, University of Mississippi Medical Center, J Source Type: research
Reconsidering the inclusion of Ladapo ’s work in the meta-analysis: Validity concerns and implications
Volume 20, Issue 1, December 2024 . (Source: Human Vaccines and Immunotherapeutics)
Source: Human Vaccines and Immunotherapeutics - February 15, 2024 Category: Allergy & Immunology Authors: Borja Somovilla Del SazIndependent researcher Source Type: research
Cost-based COVID-19 vaccination and willingness to pay: A post-pandemic review
Volume 20, Issue 1, December 2024 . (Source: Human Vaccines and Immunotherapeutics)
Source: Human Vaccines and Immunotherapeutics - February 15, 2024 Category: Allergy & Immunology Authors: Li Ping WongHai Yen LeeHaridah AliasGregory ZimetTongyu LiuYulan LinZhijian Hua Department of Epidemiology and Health Statistics, Fujian Key Laboratory of Environment Factors and Cancer, School of Public Health, Fujian Medical University, Fuzhou, Fujian, Source Type: research
The community nurse ’s role on the promotion of papillomavirus vaccination among young students: A study protocol
Volume 20, Issue 1, December 2024 . (Source: Human Vaccines and Immunotherapeutics)
Source: Human Vaccines and Immunotherapeutics - February 15, 2024 Category: Allergy & Immunology Authors: Valentina SimonettiMarco TomiettoDania ComparciniFrancesco PastorePasquale StefanizziSilvio TafuriGiancarlo Cicolinia Department of Medicine and Surgery, Casamassima, “LUM University” Giuseppe Degennaro, Bari, Italyb Department of Nursing, Midwifery, Source Type: research
Impact of the COVID-19 pandemic on social media utilization, influences related to parental vaccine decision making, and opinions on trustworthy social media vaccination campaigns: A qualitative analysis
Volume 20, Issue 1, December 2024 . (Source: Human Vaccines and Immunotherapeutics)
Source: Human Vaccines and Immunotherapeutics - February 15, 2024 Category: Allergy & Immunology Authors: Holly B. FontenotKevin M. QuistGary GlaubermanAlexandra MichelGregory Zimeta School of Nursing, University of Hawaii at Manoa, Honolulu, HI, USAb Department of Pediatrics, Herman B Wells Center for Pediatric Research, Indianapolis, IN, USAc Department of Source Type: research
The trends and hotspots of immunotherapy for metastatic colorectal cancer from 2013 to 2022: A bibliometric and visual analysis
Volume 20, Issue 1, December 2024 . (Source: Human Vaccines and Immunotherapeutics)
Source: Human Vaccines and Immunotherapeutics - February 15, 2024 Category: Allergy & Immunology Authors: Yifan GongJianping KangMingting WangFirdaus HayatiSyed Sharizman Syed Abdul RahimLucky Poh Wah Goha Faculty of Medicine and Health Science, Universiti Malaysia Sabah, Kota Kinabalu, Malaysiab Orthopedics Ward 2, Yunnan Cancer Hospital, Kunming, Chinac Onc Source Type: research
Ethical concerns regarding heterologous COVID-19 vaccine administration
Volume 20, Issue 1, December 2024 . (Source: Human Vaccines and Immunotherapeutics)
Source: Human Vaccines and Immunotherapeutics - February 14, 2024 Category: Allergy & Immunology Authors: Somsri WiwanitkitViroj Wiwanitkita Private Academic and Editorial Consultant, Bangkok, Thailandb Department of Research Analytics, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences Saveetha University India Source Type: research
Another measles outbreak in the Philippines? The essentiality of a successful vaccination program and public cooperation
Volume 20, Issue 1, December 2024 . (Source: Human Vaccines and Immunotherapeutics)
Source: Human Vaccines and Immunotherapeutics - February 13, 2024 Category: Allergy & Immunology Authors: Dalmacito A. CorderoDepartment of Theology and Religious Education, De La Salle University, Manila, Philippines Source Type: research
Relevance of mutation-derived neoantigens and non-classical antigens for anticancer therapies
Volume 20, Issue 1, December 2024 . (Source: Human Vaccines and Immunotherapeutics)
Source: Human Vaccines and Immunotherapeutics - February 13, 2024 Category: Allergy & Immunology Authors: Belen AparicioPatrick TheunissenSandra Hervas-StubbsPuri FortesPablo Sarobea Program of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA) University of Navarra, Pamplona, Spainb Cancer Center Clinica Universidad de Navarra (CCUN), P Source Type: research
